What's new

PSUSA/00001761/202404

PSUSA/00001761/202404

Mar 7, 2025 - 16:21
 0
PSUSA/00001761/202404
PSUSA/00001761/202404
Read More

Tags:

Previous Article

BMW Group: Update for the Dingolfing electric pioneer

Next Article

PSUSA/00000048/202406

Related Posts

Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Date of authorisation: 14/02/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:45 (CEST) to 9 May 2025, 15:45 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 12, 2025  0

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 April 2025, 10:00 (CEST) to 29 April 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0